Histone deacetylases as transcriptional activators? Role reversal in inducible gene regulation
- PMID: 16091625
- DOI: 10.1126/stke.2962005re11
Histone deacetylases as transcriptional activators? Role reversal in inducible gene regulation
Abstract
Histone deacetylation enzymes have often been associated with the suppression of eukaryotic gene transcription. In contrast, recent studies of inducible gene regulation indicate that protein deacetylation can also be required as a transcriptional activation signal. The concept of protein deacetylation as a requirement for transcription activation seems to contradict earlier conclusions about the function of deacetylation in gene suppression. However, in the context of a more global interpretation, these opposing effects of deacetylation imply its dynamic role in the overall control of gene expression. The exact requirement for deacetylation differs among promoters, depending on their specific architecture and regulation scenario.
Similar articles
-
Control of cardiac growth by histone acetylation/deacetylation.Circ Res. 2006 Jan 6;98(1):15-24. doi: 10.1161/01.RES.0000197782.21444.8f. Circ Res. 2006. PMID: 16397154 Review.
-
Histone acetylation in gene regulation.Brief Funct Genomic Proteomic. 2006 Sep;5(3):209-21. doi: 10.1093/bfgp/ell028. Epub 2006 Jul 28. Brief Funct Genomic Proteomic. 2006. PMID: 16877467 Review.
-
Histone acetylation and methylation: combinatorial players for transcriptional regulation.Subcell Biochem. 2007;41:351-69. Subcell Biochem. 2007. PMID: 17484136 Review.
-
Acetylation of non-histone proteins modulates cellular signalling at multiple levels.Int J Biochem Cell Biol. 2009 Jan;41(1):185-98. doi: 10.1016/j.biocel.2008.08.027. Epub 2008 Sep 2. Int J Biochem Cell Biol. 2009. PMID: 18804549 Review.
-
[Histone acetylation, gene regulation and depression].Med Sci (Paris). 2010 May;26(5):465-7. doi: 10.1051/medsci/2010265465. Med Sci (Paris). 2010. PMID: 20510142 French. No abstract available.
Cited by
-
HDAC1 Is a Required Cofactor of CBFβ-SMMHC and a Potential Therapeutic Target in Inversion 16 Acute Myeloid Leukemia.Mol Cancer Res. 2019 Jun;17(6):1241-1252. doi: 10.1158/1541-7786.MCR-18-0922. Epub 2019 Feb 27. Mol Cancer Res. 2019. PMID: 30814129 Free PMC article.
-
IRF5 is elevated in childhood-onset SLE and regulated by histone acetyltransferase and histone deacetylase inhibitors.Oncotarget. 2017 Jul 18;8(29):47184-47194. doi: 10.18632/oncotarget.17586. Oncotarget. 2017. PMID: 28525378 Free PMC article.
-
HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy.Leukemia. 2025 Jun;39(6):1412-1424. doi: 10.1038/s41375-025-02584-9. Epub 2025 Apr 2. Leukemia. 2025. PMID: 40175628 Free PMC article.
-
Combined HDAC1 and HDAC2 Depletion Promotes Retinal Ganglion Cell Survival After Injury Through Reduction of p53 Target Gene Expression.ASN Neuro. 2015 Jun 30;7(3):1759091415593066. doi: 10.1177/1759091415593066. Print 2015 May-Jun. ASN Neuro. 2015. PMID: 26129908 Free PMC article.
-
Modulation of vitamin d receptor activity by the corepressor hairless: differential effects of hairless isoforms.Endocrinology. 2009 Nov;150(11):4950-7. doi: 10.1210/en.2009-0358. Epub 2009 Oct 9. Endocrinology. 2009. PMID: 19819974 Free PMC article.